Neuropeptide Y (NPY) is a highly bioactive 36-amino acid peptide that occurs abundantly in brain. In preliminary experiments, we found that repeated administration of cocaine elicits substantial, long-lasting, biochemically-selective, and reversible reductions in levels of NPY and NPY mRNA in regions of rat cerebral cortex and nucleus accumbens. Excitotoxic lesions of medial prefrontal cortex, a region thought to be of importance for the expression of some of cocaine's reinforcing properties, did not affect NPY per se but prevented the reduction of NPY elicited by cocaine. Thus, it appears that chronic exposure to cocaine transneuronally reduces, in selected neurons, the biosynthesis of NPY, possibly in response to increases in synaptic dopamine (DA) deriving from mesolimbic/mesocortical neurons; the integrity of the medial prefrontal cortex may be crucial for cocaine's action on this neuronal network. In this study, we seek to determine regional selectivity and kinetics of cocaine/NPY interactions. The hypothesis that DA mediates cocaine's action on transcription of the NPY gene will be tested in vivo and in vitro. Moreover, the reduction in NPY may be reflected in cerebrospinal fluid and by an upregulation of NPY receptors. Finally, we will explore the possibilities that the nucleus accumbens, like the medial prefrontal cortex, is necessary for the effect, and that gestational and/or neonatal cocaine exposure affects NPY systems. We propose that NPY may be a sensitive and selective marker for chronic cocaine use. Its reduction may relate to the anxiety and depression associated with cocaine withdrawal in man.
| Akabayashi, A; Wahlestedt, C; Alexander, J T et al. (1994) Specific inhibition of endogenous neuropeptide Y synthesis in arcuate nucleus by antisense oligonucleotides suppresses feeding behavior and insulin secretion. Brain Res Mol Brain Res 21:55-61 |
| Wahlestedt, C (1994) Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol Sci 15:42-6 |
| Jazin, E E; Yoo, H; Blomqvist, A G et al. (1993) A proposed bovine neuropeptide Y (NPY) receptor cDNA clone, or its human homologue, confers neither NPY binding sites nor NPY responsiveness on transfected cells. Regul Pept 47:247-58 |
| Wahlestedt, C; Reis, D J (1993) Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets? Annu Rev Pharmacol Toxicol 33:309-52 |
| Larhammar, D; Blomqvist, A G; Yee, F et al. (1992) Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem 267:10935-8 |
